Public COA audit
NAD+ · Nicotinamide adenine dinucleotide
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 88
- Confidence
- 87%
- Panels
- 2/7
- Purity (printed)
- 99.76%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- ND20250503
- Identity method
- Ultra High Performance Liquid Chromatography with Mass Spectrometry (UHPLC-MS)
- Sample date
- 2025-07-24
- Issue date
- 2025-07-31
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
NAD+ Conforms
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.76%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Not on this COA · core
LAL or chromogenic endotoxin assay.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
99.76% purity by UHPLC-MS exceeds specification of >98%, which is normal for research-grade NAD+
Identity confirmed
Compound identity verified as NAD+ with matching CAS 53-84-9, molecular formula C21H27N7O14P2, and mass spectrometry data showing expected m/z peaks including 664.1144 (M+H)
Batch number present
Lot ND20250503 clearly documented
Dates documented
Sample received 07/24/25, analysis conducted 07/31/25 - reasonable 7-day turnaround
Lab identification present
BioRegen lab with analyst Dr. Roberto Marin, contact email, and verification URL provided
Limited testing scope
Only identity and purity panels performed. No heavy metals, microbial, endotoxin, sterility, or residual solvent testing documented
Professional presentation
Document includes chromatograms, mass spectra, calibration curve, QR code for verification, and signature
Quantity over-specification
Sample quantity 856mg exceeds specification of 500mg ± 15% (425-575mg range), marked as 'Over-Conforming' which may indicate overfill or measurement discrepancy
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.